Step into an infinite world of stories
Personal Development
"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." ―Thom Calandra, editor in chief, CBS MarketWatch
In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
• tracking the effect of breaking news and the NASDAQ
• anticipating drug trial announcements and FDA approvals
• assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.
© 2025 Times Books (Ebook): 9781466851214
Release date
Ebook: 16 October 2025
Over 950 000 titles
Kids Mode (child safe environment)
Download books for offline access
Cancel anytime
For those who want to listen and read without limits.
1 account
Unlimited Access
Unlimited listening
Cancel anytime
For those who want to listen and read without limits.
1 account
Unlimited Access
Unlimited listening
Cancel anytime
For those who want to listen and read without limits.
1 account
Unlimited Access
Unlimited listening
Cancel anytime
For those who want to share stories with family and friends.
2-3 accounts
Unlimited Access
Unlimited listening
Cancel anytime
2 accounts
S$14.90 /monthEnglish
Singapore
